Pro-drugs of adenosine receptor agonists

Details Pro-drugs of adenosine receptor agonists Pro-drugs of adenosine receptor agonists

2007-06-26

2010-10-26

Jiang, Shaojia Anna (Department: 1623)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C514S046000

Reexamination Certificate

active

07820811

ABSTRACT:
The invention relates to a method of improving oral drug absorption of adenosine analogues by the use of 2′-methoxy adenosine pro-drugs and to the use of these pro-drugs as medicaments. The invention further relates to compounds that are pro-drugs of adenosine receptor agonists, and to their use as therapeutic compounds, in particular as analgesic or anti-inflammatory compounds, or as disease modifying antirheumatic drugs (DMARDs), and to methods of preventing, treating or ameliorating pain or inflammation using these compounds.

REFERENCES:
patent: 5466786 (1995-11-01), Buhr et al.
patent: 5877180 (1999-03-01), Linden et al.
patent: 2008/0076776 (2008-03-01), Higginbottom et al.
patent: 2008/0262214 (2008-10-01), Savory
patent: 0 269 574 (1992-03-01), None
patent: 0 490 818 (1992-06-01), None
patent: 0601322 (1994-06-01), None
patent: 0997473 (2000-05-01), None
patent: 1491201 (2004-12-01), None
patent: 2 396 108 (2004-06-01), None
patent: WO-2004052377 (2004-06-01), None
patent: WO-2004078183 (2004-09-01), None
patent: WO-2004078184 (2004-09-01), None
patent: WO-2004079329 (2004-09-01), None
patent: WO-2005084653 (2005-09-01), None
Grosjean H. Topics in Current Genetics, 2005, vol. 12, p. 1-22, published online Jan. 27, 2005.
Definition of prevent, WordNet, http://wordnet.princeton.edu, accessed online Nov. 14, 2007.
Zezula et al. British Hournal of Pharmacology, 2008, 153, p. S184-S190.
Brown et al. British Journal of Pharmacology, 2008, 153, p. S446-S456.
Palmer et al. British Journal of Pharmacology, 2008, 153, p. S27-S34.
Yan et al. Expert Opin. Emerging Drugs, 2003, 8(2), p. 537-576.
Keeling, Suzanne E. et al., “The Discovery and Synthesis of Highly Potent, A2a Receptor AGonists,” Bioorganic & Medicinal Chemistry Letters, 2000, vol. 10, pp. 403-406.
Doytchinova, I. et al., “Adenosine A2A Receptor agnonists: CoMFA-based selection of the most predictive conformation,” SAR and QSAR in Environmental Research, 2002, vol. 13, No. 2, pp. 227-235.
Siddiqi et al., “Search for New Purine—and Ribose-Modified Adenosine Analogs as Selective Agonists and Antagonists at Adenosine Receptors,” J.Med.Chem., 1995, vil. 38, 1174-1188.
Van Galen et al., “A Binding Site Model and Structure-Activity Relationships for the Rat A3Adenosine Receptor,” Molecular Pharmacology, 1994, vol. 45(6), 1101-1111.
Rieger et al., “Design, Synthesis, and Evaluation of Novel A2AAdenosine Receptor Agonists,” J.Med.Chem., 2001, vol. 44, 531-539.
Zhan-Guo Gao et al., “2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors,” Biochem.Pharmacology, 2004, vol. 68, 1985-1993.
Office Action dated May 1, 2009 issued for U.S. Appl. No. 11/823,377 (Pub. No. US 2008-0076776 A1).
Response/Amendment filed on Oct. 30, 2009 in response to Office Action dated May 1, 2009 in U.S. Appl. No. 11/823,377 (Pub. No. US 2008-0076776 A1).
Written Opinion of International Searching Authority mailed Jan. 2008 for a corresponding PCT Application (PCT/EP2007/056377).
Miyai et al.: “Synthesis and Anti-Deoxyribonucleic Acid Virus Activity of Certain 9-beta-Arabinofuranosy1-2-substituted Adenine Derivatives,” J. of Med. Chem., vol. 17, No. 2, 1974, pp. 242-244.

Affiliated with

Also associated with

Rating

Pro-drugs of adenosine receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pro-drugs of adenosine receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro-drugs of adenosine receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4203029